Michael Gilman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Gilman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Gilman. Michael Gilman is EVP - Research in BIOGEN INC. ($IDPH) and Director in Scholar Rock Holding Corp ($SRRK).
Latest Insider Trading Transactions of Michael Gilman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Option Exercise | D | 26.78 | 7,800 | 208,884 | 7,800 | |
| Mar 17 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Sell | S | 65.59 | 4,696 | 307,998 | 37,459 | 42.2 K to 37.5 K (-11.14 %) |
| Feb 11 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Sell | S | 65.06 | 1,804 | 117,361 | 42,155 | 44 K to 42.2 K (-4.10 %) |
| Jan 28 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Option Exercise | M | 5.77 | 1,313 | 7,576 | 0 | |
| Jan 28 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Option Exercise | M | 5.77 | 2,188 | 12,625 | 1,314 | |
| Jan 28 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Sell | S | 59.90 | 1,518 | 90,928 | 43,959 | 45.5 K to 44 K (-3.34 %) |
| Jan 28 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Sell | S | 59.02 | 1,500 | 88,533 | 45,477 | 47 K to 45.5 K (-3.19 %) |
| Jan 28 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Sell | S | 57.99 | 483 | 28,008 | 46,977 | 47.5 K to 47 K (-1.02 %) |
| Jan 28 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Buy | M | 5.77 | 1,313 | 7,576 | 47,460 | 46.1 K to 47.5 K (+2.85 %) |
| Jan 28 2021 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Buy | M | 5.77 | 2,188 | 12,625 | 46,147 | 44 K to 46.1 K (+4.98 %) |
| Jun 18 2020 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Option Exercise | A | 17.65 | 13,000 | 229,450 | 13,000 | |
| May 23 2019 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Option Exercise | A | 21.21 | 10,158 | 215,451 | 10,158 | |
| Jun 26 2018 | SRRK | Scholar Rock Holdi ... | Gilman Michael | Director | Option Exercise | A | 21.62 | 20,316 | 439,232 | 20,316 | |
| Feb 22 2005 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Option Exercise | A | 67.57 | 70,000 | 4,729,900 | 70,000 | |
| Jan 03 2005 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Option Exercise | M | 45.46 | 5,750 | 261,395 | 23,000 | |
| Jan 03 2005 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Option Exercise | M | 44.54 | 7,000 | 311,780 | 0 | |
| Jan 03 2005 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Sell | S | 67.50 | 5,750 | 388,125 | 23,000 | 28.8 K to 23 K (-20.00 %) |
| Jan 03 2005 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Buy | M | 45.46 | 5,750 | 261,395 | 28,750 | 23 K to 28.8 K (+25.00 %) |
| Jan 03 2005 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Sell | S | 67.53 | 90 | 6,078 | 0 | 90 to 0 (-100.00 %) |
| Jan 03 2005 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Sell | S | 67.50 | 6,910 | 466,425 | 90 | 7 K to 90 (-98.71 %) |
| Jan 03 2005 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Buy | M | 44.54 | 7,000 | 311,780 | 7,000 | 0 to 7 K |
| Dec 13 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Option Exercise | M | 37.45 | 7,763 | 290,724 | 15,524 | |
| Dec 13 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Option Exercise | M | 44.54 | 7,500 | 334,050 | 7,000 | |
| Dec 13 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Sell | S | 65.00 | 7,763 | 504,595 | 15,524 | 23.3 K to 15.5 K (-33.34 %) |
| Dec 13 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Buy | M | 37.45 | 7,763 | 290,724 | 23,287 | 15.5 K to 23.3 K (+50.01 %) |
| Dec 13 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Sell | S | 65.00 | 7,500 | 487,500 | 7,000 | 14.5 K to 7 K (-51.72 %) |
| Dec 13 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Buy | M | 44.54 | 7,500 | 334,050 | 14,500 | 7 K to 14.5 K (+107.14 %) |
| Sep 15 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Option Exercise | M | 44.54 | 30,000 | 1,336,200 | 14,500 | |
| Sep 15 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Sell | S | 62.50 | 30,000 | 1,875,000 | 14,500 | 44.5 K to 14.5 K (-67.42 %) |
| Sep 15 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Buy | M | 44.54 | 30,000 | 1,336,200 | 44,500 | 14.5 K to 44.5 K (+206.90 %) |
| Aug 02 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Option Exercise | A | 59.39 | 25,000 | 1,484,750 | 25,000 | |
| Aug 02 2004 | IDPH | BIOGEN INC. | Gilman Michael | EVP - Research | Grant | A | 0.00 | 4,000 | 0 | 12,966 | 9 K to 13 K (+44.61 %) |
Page: 1